Analysis

As Featured In

Bespoke Sector Analysis

June 26, 2020
Categories
Assessment of COVID-19 Hiring Strategy May 2020
Do you like it?
Read more
June 26, 2020
Categories
Evolution Briefing: Cambrex Announce New CEO
Do you like it?
Read more
June 26, 2020
Categories
UK COVID -19 Vaccine activity
Do you like it?
Read more
June 16, 2020
Categories
Evolution Insights: The Race for a COVID -19 Vaccine
Do you like it?
Read more
June 9, 2020
Categories
Lonza accelerating efforts to make Moderna vaccine
Do you like it?
Read more
June 9, 2020
Categories
COVID Drug Strategies
Do you like it?
Read more
June 5, 2020
Categories
Evolution Insight: Pfizer and BioNtech: a lightspeed deal for potential Covid Vaccine.
Do you like it?
Read more
June 5, 2020
Categories
Evolution Briefing: Lonza announce new CEO
Do you like it?
Read more
May 6, 2020
Categories
Moderna and Lonza Announce Worldwide Collaboration to Manufacture vaccine against COVID-19
Do you like it?
Read more
February 4, 2019
Categories
Cell & Gene Therapy: Increasing Demand for Viral Vectors Drives Biomanufacturing Innovation & CDMO Investment
Do you like it?
Read more
October 24, 2018
RNAi Therapeutics Come of Age: Exploring the Peaks & Troughs of Alnylam's Thirty Year Journey to First Approval
Categories
RNAi Therapeutics Come of Age: Exploring the Peaks & Troughs of Alnylam’s Thirty Year Journey to First Approval
Do you like it?
Read more
October 10, 2018
Global Drug Development IPOs: 26 Companies Raise $3.18B in Q3 as First Pre-Revenue Biotechs List on HKEX
Categories
Global Drug Development IPOs: 26 Companies Raise $3.18B in Q3 as First Pre-Revenue Biotechs List on HKEX
Do you like it?
Read more
Load more
Contact Us